OVERVIEW

23rd Annual Lynn Sage Breast Cancer Symposium is organized by Robert H. Lurie Comprehensive Cancer Center of Northwestern University and will be held from Sep 30 - Oct 02, 2021.

Target Audience:
The target audience for this activity includes medical oncologists, radiation oncologists, surgical oncologists, fellows in training, oncology nurses and allied health professionals in breast cancer.

Overview:
For over 20 years, this multidisciplinary CME program has provided the latest information regarding cutting-edge technology and approaches in the management of breast cancer from leading national and international medical, surgical, and radiation oncologists.This year's virtual symposium will include a superb line-up of internationally recognized faculty who will not only present the latest research findings, but will also be available for real-time interaction following their presentations. The symposium will focus on the close cooperation required for effective multidisciplinary management of patients with breast cancer.

Learning Objectives:
• Recognize social determinants of health that impact on breast cancer care
• Discuss the genomic differences between populations that explain variation in disease patterns and tolerance to treatment
• Summarize the impact of enhanced breast cancer risk assessment using multiple genomic markers
• Apply genomic assays to make treatments recommendations for adjuvant treatment in ER-positive, node-positive and node negative patient populations
• Describe surgical treatment options following breast recurrence in patient who previously underwent breast conservation therapy
• Discuss the opportunities and limitations of Next-generation sequencing (NGS)
• Discuss new systemic therapies for TNBC
• Summarize the current role of CDK4/6 inhibitors in early stage breast cancer